まとめ
免疫細胞は,驚くほど少ない数の腫瘍の成長を加速させ,より高い濃度でそれを抑制することができます. これは,がんの発症初期に免疫反応が二重な役割を果たしていることを示唆している.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- がん研究 がん研究
背景:
- 癌における免疫系の役割は複雑で,完全に理解されていない.
- 免疫細胞と腫瘍細胞の相互作用を研究することは,がん治療において極めて重要です.
研究 の 目的:
- マウスモデルで腫瘍の成長に対する免疫性臓細胞の二重効果を調査する.
- 異なる数の免疫細胞が腫瘍の進行にどのように影響するかを理解する.
主な方法:
- マウスは特に免疫され,その臓細胞は標的腫瘍細胞と混合された.
- これらの混合物は,チメクトマイズされ,X放射線を受けた受容体に注射された.
- 腫瘍の成長は,免疫性の細胞の数が異なる群と対照群を比較した.
主要な成果:
- 特定の免疫性のある臓細胞の少ない数は,対照群と比較して,腫瘍の成長を著しく加速させた.
- 免疫性の細胞の数が増えると,腫瘍の成長を抑制する効果が示された.
- これらの結果は統計的に有意であり,再現可能であった.
結論:
- 正常な免疫反応は,腫瘍 (がん) で二重の機能を果たす可能性があります.
- 免疫細胞は,初期段階または最小限の免疫応答で腫瘍の成長を刺激する可能性があります.
- 逆に,免疫細胞は,異なる条件下で腫瘍の成長を抑制することができます.
関連する概念動画
Cell-mediated Immune Responses
Overview
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


